XML 33 R22.htm IDEA: XBRL DOCUMENT v3.21.2
Shareholders' Equity
9 Months Ended
Sep. 30, 2021
Stockholders Equity Note [Abstract]  
Shareholders' Equity

NOTE 15 – Shareholders’ Equity

Share count and par value data related to shareholders’ equity are as follows:

 

 

 

As of

 

 

 

September 30,

 

 

December 31,

 

 

 

2021

 

 

2020

 

Preferred Stock

 

 

 

 

 

 

 

 

Par value per share

 

No par value

 

 

No par value

 

Shares authorized

 

 

25,000,000

 

 

 

25,000,000

 

Shares outstanding

 

 

 

 

 

 

Common Stock

 

 

 

 

 

 

 

 

Par value per share

 

No par value

 

 

No par value

 

Shares authorized

 

 

75,000,000

 

 

 

75,000,000

 

Shares issued

 

 

57,235,807

 

 

 

57,076,410

 

Shares outstanding

 

 

32,288,149

 

 

 

32,276,787

 

Treasury stock

 

 

 

 

 

 

 

 

Shares held

 

 

24,947,658

 

 

 

24,799,623

 

 

On May 13, 2021, the Board of Directors approved a new share repurchase program that authorizes the Company to repurchase up to $50,000 of the Company’s common stock. The repurchase program has no set expiration date and replaces the repurchase program approved by the Board of Directors on February 7, 2019.  During the nine months ended September 30, 2021, 148,035 shares of common stock were repurchased for $4,939. During the nine months ended September 30, 2020, 342,731 shares of common stock were repurchased for $8,080. Approximately $45,061 is available for future purchases.

A roll-forward of common shares outstanding is as follows:

 

 

 

Nine months ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2021

 

 

2020

 

Balance at the beginning of the year

 

 

32,276,787

 

 

 

32,472,406

 

Repurchases

 

 

(148,035

)

 

 

(342,731

)

Restricted share issuances

 

 

159,397

 

 

 

138,276

 

Balance at the end of the period

 

 

32,288,149

 

 

 

32,267,951

 

 

 

Certain potentially dilutive restricted stock units are excluded from diluted (loss) earnings per share because they are anti-dilutive. The number of outstanding awards that were anti-dilutive for the nine months ended September 30, 2021 and 2020 were 1,029 and 68,198, respectively. There were 462 anti-dilutive awards outstanding for the three months ended September 30, 2021 and no anti-dilutive awards outstanding the three months ended September 30, 2020.